Endeavor Clinical Trials participates in bringing new non-opioid pain control medicine to the market.

Endeavor Clinical Trials was one of the sites that participated in studies investigating a non-opioid postoperative pain medicine. The sponsor, Heron Therapeutics, has announced positive topline results from its completed Phase 3 studies of the investigational agent HTX-011 in subjects undergoing bunionectomy (Study 301/EPOCH1) and hernia repair (Study 302/EPOCH2). HTX-011 achieved all primary and key secondary endpoints in both Phase 3 trials, demonstrating statistically significant reductions in both pain intensity and the use of opioid rescue medications through 72 hours following surgery.

CLICK HERE to read about the positive topline results from the phase 3 clinical trials.

STUDIES ARE ENROLLING NOW!

Nonalcoholic Fatty Liver Disease (NAFLD)

NAFLD is the most common form of chronic liver disease in the US. Find out if you’re at risk today by taking part in a clinical trial enrolling now. 

Knee Pain

Apply to participate in a study of an investigational pain medication following a knee replacement.

Smoking Study

Are you a current smoker? You may qualify for a clinical trial evaluating various heated tobacco products.